Abstract
Background During cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, body temperature rapidly changes due to the hyperthermic agent. Depending on the method used, obtained values may vary, particularly during localized heating of the abdominal cavity. The primary aim of our study was to compare the effectiveness of core temperature monitoring techniques, nasopharyngeal temperature, zero-heat flux cutaneous thermometer device, and esophageal temperature, during hyperthermic intraperitoneal chemotherapy with cytoreductive surgery.
Methods Body temperature was measured using a zero-heat flux cutaneous thermometer device on the forehead and esophageal and nasopharyngeal probes throughout the surgery. Temperature differences were then calculated for each pair of measurements. We conducted an agreement analysis between the nasopharyngeal temperature and reference core temperature measurements using the 95% Bland–Altman limits of agreement for repeated measurement data. The proportion of all differences that were within 0.5 °C and repeated measures Lin’s concordance correlation coefficient were estimated.
Results The mean overall difference between nasopharyngeal and forehead temperature was -0.04 ± 0.33 °C (95% limits of agreement: -0.69–0.62), and esophageal temperature was 0.02 ± 0.35°C (95% limits of agreement: -0.66–0.71). The proportion of differences within 0.5 °C of TSpotOn was 0.03 (95% CI 0.01–0.04) and that of esophageal temperature was -0.06 (95% CI -0.08 to -0.05). The Lin’s concordance correlation coefficient of both were 0.94 (95% CI 0.93–0.94). After the hyperthermic intraperitoneal chemotherapy period, the temperatures rapidly decreased, followed by a noticeable rebound increase, particularly nasopharyngeal and forehead temperatures. The maximum difference between esophageal temperature and other temperatures was 1.5 °C.
Conclusions Our results reveal a strong correlation between nasopharyngeal, zero-heat flux cutaneous, and esophageal temperatures during surgery. However, consistent temperature differences with the esophageal thermometer were not observed. Post-hyperthermic intraperitoneal chemotherapy, rebound heating occurred at all sites, notably in the nasopharyngeal and zero-heat flux cutaneous areas.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
CRiS Registration number: KCT0003980 Cris.nih.go.kr
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study received approval from the Ethics Committee for Research with Medicine of CHA Bundang Medical Center, CHA University Hospital, Gyeonggi–do, Korea on August 5th, 2019 (approval number: CHAMC–04–050 registration number: KCT0003980). Written informed consent was obtained from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data files are available from the Department of Anesthesiology and Pain Medicine, CHA Bundang Medical Centervdatabase (accession via 0000-0002-2990-528X).
